Status:
NOT_YET_RECRUITING
Symptom Monitoring With Supported Feedback in Advanced Chronic Kidney Disease
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Chronic Kidney Disease (Stages 4 and 5)
Health Related Quality of Life
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patient-reported outcome measures (PROMs) are validated tools to reliably measure outcomes highly prioritized by patients, such as health-related quality of life (HRQOL) and symptoms, but the current ...
Eligibility Criteria
Inclusion
- Adults (age ≥ 18 years)
- Advanced CKD, defined as at least two measurements of creatinine-based or cystatin C-based eGFR ≤ 30 mL/min/1.73m2 separated by at least 90 days in the preceding 12 months
- Able to provide consent to participate in the study
- Able to read and write in English
- Under the care of a nephrologist at a Mass General Brigham nephrology clinic
Exclusion
- Terminal illness likely to lead to death within 6 months of participation
- Patients receiving dialysis treatment at the time of enrollment or scheduled to start dialysis therapy in the next 4 weeks
- Patients scheduled to receive a kidney transplant in the next 6 months
- Patients having their initial clinic visit (i.e., new to the clinic)
- Cognitive deficits that would preclude understanding of consent form and/or questionnaires
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2029
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT07186218
Start Date
November 1 2025
End Date
December 31 2029
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mass General Brigham
Boston, Massachusetts, United States, 02114